Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 7, 2007 - Issue 7
Submit an article Journal homepage
64
Views
2
CrossRef citations to date
0
Altmetric
Review

New approaches in systemic treatment of advanced colorectal cancer: the molecular targets era

Jaume Capdevila Medical Oncologist, Vall d’Hebron University Hospital, Medical Oncology Department, Barcelona, Spain. [email protected]
,
Guillermo Mendez Medical Oncologist, Hospital Municipal de Gastroenterología del Gobierno de la Ciudad de Buenos Aires ‘Carlos B. Udaondo’, Buenos Aires, Argentina. [email protected]
,
Teresa Macarulla Medical Oncologist, Vall d’Hebron University Hospital, Medical Oncology Department, Barcelona, Spain. [email protected]
,
Francisco Javier Ramos Medical Oncologist, Vall d’Hebron University Hospital, Medical Oncology Department, Barcelona, Spain. [email protected]
,
Esther Casado Medical Oncologist, Vall d’Hebron University Hospital, Medical Oncology Department, Barcelona, Spain. [email protected]
&
Josep Tabernero Medical Oncologist, Vall d’Hebron University Hospital, Medical Oncology Department, Barcelona, Spain. [email protected]
Pages 1027-1041 | Published online: 10 Jan 2014

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Steven A Haney. (2007) Expanding the repertoire of RNA interference screens for developing new anticancer drug targets. Expert Opinion on Therapeutic Targets 11:11, pages 1429-1441.
Read now

Articles from other publishers (1)

José María Viéitez, Manuel Valladares, Ignacio Peláez, Luis de Sande González, Jesús García-Foncillas, José Luis García-López, Carlos García-Girón, Margarita Reboredo, Humberto Bovio & Angel Jiménez Lacave. (2010) A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143). Investigational New Drugs 29:5, pages 1038-1044.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.